4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-020621
Options or other derivatives
- Chief Executive Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BLATT LAWRENCE Chief Executive Officer | 2020-12-01 | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…